Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04667520 · ClinicalTrials.gov registry record · NA
Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment
A NA study of Depression and Alcohol Use Disorder, sponsored by Butler Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 214
- Enrollment target
- 1
- Study location
NCT04667520: Recruiting NA study of Depression and Alcohol Use Disorder, sponsored by Butler Hospital.
NCT04667520 is a NA study of Depression and Alcohol Use Disorder that is actively recruiting participants, run by Butler Hospital. The registered enrollment target is 214 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04667520, a NA study of Depression and Alcohol Use Disorder, is actively recruiting participants, sponsored by Butler Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 214 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this project is to test the efficacy of a technology-supported lifestyle physical activity (LPA) intervention for preventing relapse among women with depression engaged in alcohol treatment. Participants are randomized to either 1) LPA+Fitbit intervention or 2) Fitbit Only control condition. Follow-up assessments and EMA data will be collected.
Primary Outcome
Timeline Follow-back Interview will be used to determined whether participants drank any alcohol during the time frame assessed.
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle Physical Activity (LPA)
- BEHAVIORAL Fitbit Only
Study Locations (1)
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 214 participants |
| Start Date | 2021-05-10 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT04667520 shows while recruiting
NCT04667520 is an interventional study that assigns participants to a tested intervention. The registered 214 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Lifestyle Physical Activity (LPA) is the first listed.
NCT04667520 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT04667520 about?
NCT04667520 is a clinical study titled "Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment". The primary aim of this project is to test the efficacy of a technology-supported lifestyle physical activity (LPA) intervention for preventing relapse among women with depression engaged in alcohol treatment. Participants are randomized to either 1) LPA+Fitbit intervention or 2) Fitbit Only control...
What is the current status of trial NCT04667520?
This trial is currently recruiting. It is a NA study. The enrollment target is 214 participants. The study started on 2021-05-10. Estimated completion is 2026-06-30.
What conditions does trial NCT04667520 study?
This clinical trial studies the following conditions: Depression, Alcohol Use Disorder.
What interventions are being tested in trial NCT04667520?
The interventions under investigation include: Lifestyle Physical Activity (LPA) (BEHAVIORAL), Fitbit Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT04667520?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04667520 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04667520's enrollment target sits among peer trials
214 199th of 679 higher than 481 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04030507 · 214 participants · NA
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
- NCT04421248 · 214 participants · Phase 4
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
- NCT05418868 · 214 participants · Phase 1
A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult Participants
- NCT05483465 · 214 participants · Phase 4
The Effect of NAD Supplementation on Brain Vascular Health in Aging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy